Shanghai Bracco Sine Pharmaceutical Competitors and Similar CompaniesClear all

Shanghai Bracco Sine Pharmaceutical's competitors and similar companies include Guerbet, Eckert & Ziegler, Universal Medical Resources and Technodomus.

	Shanghai Bracco Sine Pharmaceutical Shanghai Bracco Sine Pharmaceutical (上海博莱科信谊药业有限责任公司) is a manufacturer of imaging diagnostics and medical devices.	Guerbet Guerbet SA researches and develops, manufactures, and distributes medical imaging products in Europe and internationally.	Eckert & Ziegler Eckert & Ziegler provides isotope technology components for medical, scientific, and industrial use.	Universal Medical Resources Universal Medical Resources is a provider of healthcare solutions.	Technodomus Technodomus is a supplier of medical equipment.
Founding Date	Founding Date 2001	Founding Date 1926	Founding Date 1997	Founding Date 1996	Founding Date 2002
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare medical devices medical imaging pharma	Tags Healthcare medical devices medical imaging pharma	Tags Healthcare Manufacturing & Industrial healthtech medical devices medical imaging oncology pharma	Tags Healthcare medical devices medical imaging pharma	Tags Healthcare medical devices medical imaging pharma rental
Locations	Locations Milano, IT HQ Milano, IT	Locations Villepinte, FR HQ Lane Cove West, AU Wien, AT Bruxelles, BE Pointe Claire, CA see more	Locations Berlin, DE HQ Buenos Aires, AR São Paulo, BR Changzhou, CN Praha, CZ Courtaboeuf, FR Paris, FR see more	Locations Washington, US HQ	Locations Ciudad de México, MX HQ
Employees	Employees 422% decrease	Employees 2,778	Employees 1,094	Employees 1491% increase	Employees 46
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €786.4m (FY, 2025)	Revenue (est.) €312m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €199.3m (FY, 2025)	Cost of goods €147.7m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €604.1m (FY, 2025)	Gross profit €166.8m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (€112.7m) (FY, 2025)	Net income €49.2m (FY, 2025)	Net income N/A	Net income N/A